| Title | Estimation of Cost for Endoscopic Screening for Esophageal Cancer in a High-Risk Population in Rural China: Results from a Population-Level Randomized Controlled Trial |
| Authors | Li, Fuxiao Li, Xiang Guo, Chuanhai Xu, Ruiping Li, Fenglei Pan, Yaqi Liu, Mengfei Liu, Zhen Shi, Chao Wang, Hui Wang, Minmin Tian, Hongrui Liu, Fangfang Liu, Ying Li, Jingjing Cai, Hong Yang, Li He, Zhonghu Ke, Yang |
| Affiliation | Peking Univ Canc Hosp & Inst, Lab Genet, Minist Educ Beijing, Key Lab Carcinogenesis & Translat Res, 52 Fucheng Rd, Beijing 100142, Peoples R China Anyang Canc Hosp, Anyang, Henan, Peoples R China Hua Cty Peoples Hosp, Anyang, Henan, Peoples R China Peking Univ, Sch Publ Hlth, Beijing, Peoples R China |
| Issue Date | 2019 |
| Publisher | PHARMACOECONOMICS |
| Abstract | Background and ObjectivePopulation-level endoscopic screening for esophageal cancer has been conducted in China for years. In this study, we aim to provide an updated and precise cost estimation for esophageal cancer screening based on a randomized controlled trial in a high-risk area in China.MethodsWe estimated the cost of esophageal cancer screening with chromoendoscopy using a micro-costing approach based on primary data of the ESECC (Endoscopic Screening for Esophageal Cancer in China) randomized controlled trial (NCT01688908) from a health sector perspective. Unit costs and quantities of resources were collected to obtain annual screening costs. The screening project was then theoretically expanded to a 10-year period to explore long-term trends of costs. Costs were adjusted to US dollars for the year 2018.ResultsIn the ESECC trial, screening cost per endoscopy with a valid pathologic diagnosis was $196, accounting for 3.82% of the gross domestic product per capita in Hua County, and the costs for detecting one esophageal cancer and one early-stage esophageal cancer were $26,347 and $37,687, respectively. In conventional screening in which protocol-driven costs were excluded, costs as above were $134, $18,074, and $25,853. The cost for detecting one gastric cardia cancer or stomach cancer was nine times higher than detecting one esophageal cancer owing to low prevalences of the two cancers. In a simulated 10-year screening project, annual cost decreased notably over time.ConclusionsDespite the relatively low absolute cost, population-level endoscopic screening will still be a heavy burden on local government considering the socioeconomic conditions. Long-lasting programs would be less costly and population-level screening would make little sense in non-high-risk regions. |
| URI | http://hdl.handle.net/20.500.11897/547929 |
| ISSN | 1170-7690 |
| DOI | 10.1007/s40273-019-00766-9 |
| Indexed | SCI(E) SSCI(E) EI |
| Appears in Collections: | 北京肿瘤医院 公共卫生学院 |
